RESEARCH STUDY
Clinical Research for Adults Living With MASH (Metabolic Dysfunction–Associated Steatohepatitis)
If you’re an adult diagnosed with MASH—formerly known as NASH—you may be eligible for an investigational clinical research study evaluating potential new treatment options. MASH can progress silently over time, and researchers are working to better understand how investigational therapies may help support liver health.
RESEARCH STUDY
Clinical Research for Adults Living With MASH (Metabolic Dysfunction–Associated Steatohepatitis)
If you’re an adult diagnosed with MASH—formerly known as NASH—you may be eligible for an investigational clinical research study evaluating potential new treatment options. MASH can progress silently over time, and researchers are working to better understand how investigational therapies may help support liver health.
RESEARCH STUDY
Clinical Research for Adults Living With MASH (Metabolic Dysfunction–Associated Steatohepatitis)
If you’re an adult diagnosed with MASH—formerly known as NASH—you may be eligible for an investigational clinical research study evaluating potential new treatment options. MASH can progress silently over time, and researchers are working to better understand how investigational therapies may help support liver health.
Participants Receive
Study-related medical assessments at no cost
Study-related liver health evaluations at no cost
Compensation up to $2,000
About MASH (Metabolic Dysfunction–Associated Steatohepatitis)
MASH is a progressive liver condition associated with metabolic dysfunction, including obesity, type 2 diabetes, high cholesterol, and insulin resistance. It involves fat buildup and inflammation in the liver that may lead to fibrosis or, in more severe cases, cirrhosis.
Many individuals with MASH experience little to no symptoms, which makes early detection and research into new treatment options especially important. Researchers are evaluating potential therapies to better support liver health and slow disease progression.
MASH Clinical Research Study – Now Screening Participants
Adults 18 and older who have been diagnosed with MASH may qualify for a clinical research study evaluating an investigational treatment designed to target liver inflammation and metabolic dysfunction. All study-related assessments and care are provided at no cost.
By participating, you will receive study-related health evaluations from a dedicated research team working to advance understanding and future treatment options for MASH.
You May Qualify If
Are 18 years or older
Have been diagnosed with MASH (or NASH)
To see if you are eligible, please complete the form to get in touch with the study team.
Your privacy is important to us. By completing the following pre-screener you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.